Bart E. Burington
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 3
- Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Jesse R. Fann (4 shared papers)Wayne J. Katon (4 shared papers)Bart Barlogie (7 shared papers)John D. Shaughnessy (7 shared papers)Fenghuang Zhan (6 shared papers)John Crowley (6 shared papers)Kenneth M. Jaffe (2 shared papers)Robert S. Thompson (2 shared papers)
- Journals
- Blood (12 papers)Cancer (2 papers)Clinical Cancer Research (2 papers)Annals of Oncology (1 paper)Blood Advances (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Bart E. Burington
26 papers receiving 2.3k citations
Bart E. Burington's Hit Papers
Peers
Comparison fields: 5 of 96
- Hematology 1.1k
- Genetics 261
- Critical Care and Intensive Care Medicine 102
- Oncology 486
- Molecular Biology 1.1k
Countries citing papers authored by Bart E. Burington
This map shows the geographic impact of Bart E. Burington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart E. Burington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart E. Burington more than expected).
Fields of papers citing papers by Bart E. Burington
This network shows the impact of papers produced by Bart E. Burington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart E. Burington. The network helps show where Bart E. Burington may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart E. Burington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 848 |
| 2 | 2006 | 360 | |
| 3 | 2004 | 318 | |
| 4 | 2015 | 162 | |
| 5 | 2014 | 148 | |
| 6 | 2004 | 89 | |
| 7 | 2004 | 83 | |
| 8 | 2002 | 81 | |
| 9 | 2005 | 76 | |
| 10 | 2023 | 44 | |
| 11 | 2023 | 43 | |
| 12 | 2008 | 37 | |
| 13 | 2003 | 26 | |
| 14 | 2012 | 15 | |
| 15 | 2009 | 11 | |
| 16 | 2019 | 11 | |
| 17 | 2020 | 9 | |
| 18 | 2006 | 4 | |
| 19 | 2005 | 4 | |
| 20 | 2005 | 2 |
About Bart E. Burington
Bart E. Burington is a scholar working on Hematology, Genetics, Radiology, Nuclear Medicine and Imaging, Critical Care and Intensive Care Medicine and Rheumatology, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Glycosylation and Glycoproteins Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Protein Degradation and Inhibitors (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Traumatic Brain Injury Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (261 citations), Critical Care and Intensive Care Medicine (102 citations), Oncology (486 citations) and Molecular Biology (1.1k citations). Bart E. Burington has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jesse R. Fann, Wayne J. Katon, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, John Crowley, Kenneth M. Jaffe, Robert S. Thompson, Ichiro Hanamura and Jeffrey R. Sawyer. Their work appears in journals such as Blood, Cancer, Clinical Cancer Research, Annals of Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.